Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pyridam Farma Tbk (PYFA) vs Solusi Bangun Indonesia Tbk. (SMCB) Price & Performance

Pyridam Farma TbkTrade
Solusi Bangun Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Pyridam Farma Tbk vs Solusi Bangun Indonesia Tbk. — how do they compare? Pyridam Farma Tbk trades at Rp252 (market cap 2.85T, 14.4M 24h volume), while Solusi Bangun Indonesia Tbk. trades at Rp775 (market cap 6.99T). The key difference: Solusi Bangun Indonesia Tbk. is far larger — about 2.5× Pyridam Farma Tbk's market cap. Which is the better fit depends on your goals.

PYFASMCB
Market Cap
2.85T6.99T
Volume
14.4M
Lot
144.05K
Turnover
3.62B
Average Price
251.34
Value
3.62B
Indicative Equilibrium Price
252
Indicative Equilibrium Volume
363

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PYFA
View details
SMCB
View details

About Pyridam Farma Tbk

PT. Pyridam Farma Tbk. Founded in Jakarta based on Limited Company Act on November 27th 1976 and start the commercial operation since 1978 which conduct in pharmaceutical business.On its first establishmnent, the corporate produce & distribute medicine products for livestock & pet.. Since 1985 the corporate develop pharmacy division which emphasize produce and distribute health product for human and for livestock held by veterinary division.

Read more on PYFA

About Solusi Bangun Indonesia Tbk.

PT Holcim Indonesia Tbk (the Company) was originally a joint venture between a subsidiary of Kaiser Cement and Gypsum Corp. and PT Semen Gresik. Founded in 1971, the company owns a factory in Narogong, West Java, with an annual capacity of 3 million tons. The Company changed its foreign capital investment status (PMA) to domestic capital investment (PMDN) based on the approval from Chairman of Capital Investment Coordinating Board No. 17/V/1988 dated November 19, 1988. Effective January 1, 2006, the Company changed its name from PT Semen Cibinong Tbk. to PT Holcim Indonesia Tbk.

Read more on SMCB